Home

Left ventricle myocardial hypertrophy: the probability of occurrence and duration

Written by Lazutkina A.Yu., Gorbunov V.V.

  UDK: 616.124.2/.127-007.61 | Pages: 52–55 | Full text PDF | Open PDF 

Annotation:
Methods. The study of 2008–2013 involved 7959 workers aged 18–66 years of locomotive brigades of Trans-Baikal Railway, who suffered from cardiovascular diseases with the exception of essential hypertension 1 degree of stage I–II. We searched for risk factors, target lesions of cardiovascular disease with determination from among the predictors of LVMH. Results. In the first stage of research for LVMH established the following predictors: hypertension, age, retinopathy, diabetes, thickening of the complex «intima-media» more than 0.9 mm / atherosclerotic plaques of carotid arteries, body mass index greater than 25, aortic atherosclerosis, hyperglycemia and stress. The second stage was analyzed the survival function. Graphical evaluation of Kaplan-Meier method showed that it was dependent on the body mass index, presence of hypertension, hyperglycemia, retinopathy, arteriosclerosis of the aorta, carotid arteries subclinical and age. Stress as an independent risk factor had no value. Conclusions. Predictors of LVMH in its subclinical characteristics are heterogeneous in size damaging impact, the implementation of progressive course of endothelial dysfunction through an independent impact, or in combination with other predictors. LVMH is determined by the influence of not only traditional risk factors, but also the mutual negative effect of target organ damage.

Links to authors:

A.Yu. Lazutkina1, V.V. Gorbunov2
1 Regional management office of medical supply on Trans-Baikal Railway (117 Chkalova St. Chita 672000 Russian Federation),
2 Chita State Medical Academy (39a Gorkogo St. Chita 672090 Russian Federation)


1. Volobuev A.N., Petrov E.S. Age development of SAD syndrome and primary hypertension // Health & Education Millenium. 2013. Vol. 15, No. 1–4. P. 360–361.
2. Grebenkina I.A., Popova A.A., Yakovleva I.V. [et al.]. Criterion of progressive endothelial dysfunction in hypertensive patients // Siberian Medical Review. 2011. Vol. 71, No. 5. P. 13–17.
3. Diagnosis and treatment of hypertension. Recommendations of Russian Medial Society on arterial hypertension and of Society of Cardiology of Russian Federation // Cardiovascular Therapy and Prevention. 2008. Vol. 7, No. 6. Appx. 2. P. 1–32.
4. Cardiovascular Prevention. Recommendationas of Society of Cardiology of Russian Federation // Cardiovascular Therapy and Prevention. 2011. Vol.10, No. 6. Appx. 2 P. 1–64.
5. Kilessa V.V. Myocardial infarction – a consequence of the redistribution of intracardiac blood microcirculation? // Tavricheskiy Mediko-Biologicheskiy Vestnik. 2010. Vol. 13, No. 4. P. 209–213.
6. Lazutkina A.Yu., Gorbunov V.V. Risk factors and progression of left ventricular hypertrophy // Saratov Journal of Medical Scientific Research. 2015. No. 2. P. 141–145.
7. Stropus R.A. Cholinergic and adrenergic innervation of the heart and its changes in cardiovascular pathology: thesis abstract, MD. М., 1982. 35 p.
8. Shvalev V.N., Sosunov A.A., Guski G. Morphological bases of cardiac innervation. М.: Nauka, 1992. 365 p.
9. Shavalev V.N., Tarskiy N.A. The phenomenon of early age involution of the sympathetic division of the autonomic nervous system // Kardiologiia. 2001. No. 2. P. 10–14.
10. Aird W.C. Endothelium as an organ system // Crit. Care. Med. 2004. Vol. 32 (5 Suppl.). Р. S271–279.
11. Borchard F. The adrenergic nerves of the normal and the hypertrophied heart: biochemical, histochemical, electronmicroscopic and morphometric studies. Normal and Pathologic Anatomy Series (Vol. 33). Thieme, 1978. 68 p.
12. Heil S.G, De Vriese A.S., Kluijtmans L.A. [et al.]. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation // Cell. Mol. Biol. (Noisy-le-grand). 2004. Vol. 50, No. 8. Р. 911–916.
13. Pickering T.G. Mental stress as a casual factor in the development of hypertension and cardiovascular disease // Curr. Hypertens. Rep. 2001. No. 3. Р. 249–254.
14. Schachinger V., Britten MB., Zeiger AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease // Circulation. 2000. No. 101. Р. 1899–1906.
15. Sciacqua А., Borrello F., Vatrano М. [et al.]. Effect of interaction between left ventricular dysfunction and endothelial function in hypertension // Current Hypertension Reports. 2006. Vol. 8, No. 3. Р. 212–218.

PUBLISHER: "MEDITSYNA DV"

Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.